Patrick Donnelly
Stock Analyst at Citigroup
(4.24)
# 454
Out of 4,496 analysts
210
Total ratings
60.87%
Success rate
10.86%
Average return
Main Sectors:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Upgrades: Buy | $145 → $165 | $146.01 | +13.01% | 8 | Jul 10, 2024 | |
| ILMN Illumina | Upgrades: Buy | $140 | $114.49 | +22.28% | 9 | Jul 10, 2024 | |
| AVTR Avantor | Downgrades: Neutral | $30 → $23 | $20.85 | +10.31% | 7 | Jul 10, 2024 | |
| A Agilent Technologies | Upgrades: Buy | $135 → $150 | $131.78 | +13.83% | 16 | Jul 10, 2024 | |
| TECH Bio-Techne | Downgrades: Neutral | $85 | $75.46 | +12.64% | 8 | May 22, 2024 | |
| MTD Mettler-Toledo International | Maintains: Sell | $975 → $1,200 | $1,344.26 | -10.73% | 4 | May 13, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $100 → $80 | $46.81 | +70.90% | 10 | May 9, 2024 | |
| DHR Danaher | Maintains: Buy | $280 → $290 | $243.54 | +19.08% | 8 | Apr 24, 2024 | |
| SHC Sotera Health Company | Upgrades: Buy | $18 → $16 | $13.09 | +22.23% | 2 | Apr 3, 2024 | |
| HOLX Hologic | Upgrades: Buy | $80 → $95 | $78.11 | +21.62% | 8 | Apr 3, 2024 | |
| BIO.B Bio-Rad Laboratories | Downgrades: Neutral | $400 → $365 | $294.23 | +24.05% | 9 | Apr 3, 2024 | |
| BIO Bio-Rad Laboratories | Downgrades: Neutral | $400 → $365 | $296.82 | +22.97% | 9 | Apr 3, 2024 | |
| TMO Thermo Fisher | Reinstates: Neutral | $620 | $534.35 | +16.03% | 16 | Mar 18, 2024 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $250 | $218.24 | +14.55% | 10 | Feb 15, 2024 | |
| BRKR Bruker | Maintains: Buy | $80 → $95 | $61.89 | +53.50% | 6 | Feb 14, 2024 | |
| QGEN Qiagen | Maintains: Buy | $62 → $60 | $41.55 | +44.40% | 13 | Feb 8, 2024 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $34 → $40 | $26.03 | +53.67% | 2 | Dec 11, 2023 | |
| WAT Waters | Maintains: Neutral | $265 → $300 | $302.72 | -0.90% | 14 | Dec 11, 2023 | |
| QDEL QuidelOrtho | Downgrades: Neutral | $95 → $72 | $34.69 | +107.55% | 3 | Dec 11, 2023 | |
| OSUR OraSure Technologies | Maintains: Buy | $7 → $9 | $4.20 | +114.29% | 4 | Dec 11, 2023 | |
| IQV IQVIA Holdings | Maintains: Neutral | $190 → $225 | $224.57 | +0.19% | 7 | Dec 11, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $300 → $315 | $329.70 | -4.46% | 7 | Dec 11, 2023 | |
| GH Guardant Health | Reiterates: Buy | $50 | $30.75 | +62.60% | 7 | Oct 2, 2023 | |
| SERA Sera Prognostics | Maintains: Neutral | $3.75 → $2.75 | $7.80 | -64.74% | 4 | Aug 10, 2023 | |
| TXG 10x Genomics | Maintains: Buy | $65 → $75 | $16.70 | +349.10% | 8 | Aug 4, 2023 | |
| STVN Stevanato Group | Maintains: Buy | $30 → $35 | $21.38 | +63.70% | 3 | May 5, 2023 | |
| LH Labcorp Holdings | Maintains: Neutral | $250 → $260 | $211.37 | +23.01% | 3 | Feb 17, 2023 | |
| PSNL Personalis | Maintains: Buy | $8 → $6 | $3.85 | +55.84% | 4 | Nov 3, 2022 | |
| MYGN Myriad Genetics | Upgrades: Neutral | n/a | $25.97 | - | 1 | Nov 30, 2018 |
Quest Diagnostics
Jul 10, 2024
Upgrades: Buy
Price Target: $145 → $165
Current: $146.01
Upside: +13.01%
Illumina
Jul 10, 2024
Upgrades: Buy
Price Target: $140
Current: $114.49
Upside: +22.28%
Avantor
Jul 10, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $20.85
Upside: +10.31%
Agilent Technologies
Jul 10, 2024
Upgrades: Buy
Price Target: $135 → $150
Current: $131.78
Upside: +13.83%
Bio-Techne
May 22, 2024
Downgrades: Neutral
Price Target: $85
Current: $75.46
Upside: +12.64%
Mettler-Toledo International
May 13, 2024
Maintains: Sell
Price Target: $975 → $1,200
Current: $1,344.26
Upside: -10.73%
Exact Sciences
May 9, 2024
Maintains: Buy
Price Target: $100 → $80
Current: $46.81
Upside: +70.90%
Danaher
Apr 24, 2024
Maintains: Buy
Price Target: $280 → $290
Current: $243.54
Upside: +19.08%
Sotera Health Company
Apr 3, 2024
Upgrades: Buy
Price Target: $18 → $16
Current: $13.09
Upside: +22.23%
Hologic
Apr 3, 2024
Upgrades: Buy
Price Target: $80 → $95
Current: $78.11
Upside: +21.62%
Bio-Rad Laboratories
Apr 3, 2024
Downgrades: Neutral
Price Target: $400 → $365
Current: $294.23
Upside: +24.05%
Bio-Rad Laboratories
Apr 3, 2024
Downgrades: Neutral
Price Target: $400 → $365
Current: $296.82
Upside: +22.97%
Thermo Fisher
Mar 18, 2024
Reinstates: Neutral
Price Target: $620
Current: $534.35
Upside: +16.03%
Charles River Laboratories International
Feb 15, 2024
Maintains: Neutral
Price Target: $215 → $250
Current: $218.24
Upside: +14.55%
Bruker
Feb 14, 2024
Maintains: Buy
Price Target: $80 → $95
Current: $61.89
Upside: +53.50%
Qiagen
Feb 8, 2024
Maintains: Buy
Price Target: $62 → $60
Current: $41.55
Upside: +44.40%
Fortrea Holdings
Dec 11, 2023
Upgrades: Buy
Price Target: $34 → $40
Current: $26.03
Upside: +53.67%
Waters
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $302.72
Upside: -0.90%
QuidelOrtho
Dec 11, 2023
Downgrades: Neutral
Price Target: $95 → $72
Current: $34.69
Upside: +107.55%
OraSure Technologies
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $4.20
Upside: +114.29%
IQVIA Holdings
Dec 11, 2023
Maintains: Neutral
Price Target: $190 → $225
Current: $224.57
Upside: +0.19%
ICON PLC
Dec 11, 2023
Maintains: Buy
Price Target: $300 → $315
Current: $329.70
Upside: -4.46%
Guardant Health
Oct 2, 2023
Reiterates: Buy
Price Target: $50
Current: $30.75
Upside: +62.60%
Sera Prognostics
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $7.80
Upside: -64.74%
10x Genomics
Aug 4, 2023
Maintains: Buy
Price Target: $65 → $75
Current: $16.70
Upside: +349.10%
Stevanato Group
May 5, 2023
Maintains: Buy
Price Target: $30 → $35
Current: $21.38
Upside: +63.70%
Labcorp Holdings
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $211.37
Upside: +23.01%
Personalis
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $3.85
Upside: +55.84%
Myriad Genetics
Nov 30, 2018
Upgrades: Neutral
Price Target: n/a
Current: $25.97
Upside: -